Press Release KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC) 28 February 2026
Press Release WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) 28 February 2026
Press Release Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034 28 February 2026
Press Release Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034 28 February 2026
Press Release National Condom Month: Why Today’s Protection Is About Pleasure, Confidence and Connection, According to Sex & Relationship Expert, Dr. Deb Laino 27 February 2026
Press Release The Baldwin Group Announces Future Leadership Transition in its Underwriting, Capacity, and Technology Solutions Segment 27 February 2026
Press Release PSFE INVESTOR REMINDER: Paysafe Limited Investors Have Until April 7, 2026 To Seek Lead Plaintiff Role 27 February 2026
Press Release INVESTOR ALERT: Securities Class Action Filed Against Franklin BSP Realty Trust, Inc. – Investors Encouraged to Contact Kirby McInerney LLP 27 February 2026
